期刊文献+

N-糖链切除对重组抗狂犬病毒单克隆抗体中和活性的影响 被引量:1

Effect of the N-glycan Removal on the Neutralization Activity of Recombinant Anti-rabies Monoclonal Antibodies
下载PDF
导出
摘要 重组抗狂犬病毒单克隆抗体是一种全人源的抗病毒感染单抗,主要用于狂犬病毒暴露后预防。采用糖苷酶处理2种重组抗狂犬病毒单克隆抗体Mab1、Mab2水解切除N-糖链,通过糖染色和毛细管电泳检测确定N-糖链酶解程度,利用快速荧光灶抑制试验检测其中和活性,分析N-糖链切除对该单抗中和活性的影响。结果显示,N-糖链切除后抗体中和活性无明显变化。说明N-糖链对这两株抗狂犬病毒单抗的体外中和活性不是必须的结构成分。 The recombinant anti-rabies monoclonal antibody were fully-human-derived antibody and were used for post-explosure prophylaxis of rabies virus. The N- glycan of two anti-rabies monoclonal antibodies( Mab1 and Mab2) were hydrolyzed by the PNGase in this study,the capillary electrophoresis and gel staining by periodic acid-schiff method were used to determine the residual N-glycan after hydrolysis. The rapid fluorescent focus inhibition test was used to compare the neutralization bio-activity of the intact Mab1 and the Mab2 without N-glycan. The result showed that the neutralization bioactivity of Mab1 and Mab2 did not change after the N-glycan was removed from the antibodies. That suggests the N-glycan was not the indispensable composition for in-vitro neutralization bioactivity of Mab1 and Mab2.
出处 《生物技术进展》 2016年第4期277-282,共6页 Current Biotechnology
基金 "十二五"国家科技重大专项(2014ZX09201041)资助
关键词 重组抗狂犬病毒单克隆抗体 N-糖链切除 毛细管电泳 中和活性 recombinant anti-rabies virus monoclonal antibody N-glycan removal capillary electrophoresis neutralization activity
  • 相关文献

参考文献4

二级参考文献42

  • 1Mizuochi T, Hamako J, Titani K. Structures of the sugar chains of mouse immunoglobulin G. Arch Biochem Biophys, 1987,257 ( 2 ) :387.
  • 2Rothman RJ, Warren L, Vliegenthart JF, et al. Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. Biochemistry, 1989,28 ( 3 ) : 1377.
  • 3Matsumiya S, Yamaguchi Y, Saito J, et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobu- lin G1. J Mol Bio1,2007,368 (3) :767.
  • 4Krapp S, Mimura Y. Structural analysis of human IgG - Fe glyco- forms reveals a correlation between glycosylation and structural integ- rity. J Mol Biol,2003,325( 5 ) :979.
  • 5Shields RL, Lai J. Lack of fucose on human IgG1 N - linked oligo- saccharide improves binding to human Fcgamma RIII and antibody - dependent cellular toxicity. J BioI Chem ,2002,277 (30) :26733.
  • 6Davies J, Jiang L, Pan LZ, et al. Expression of GnTIII in a recombi- nant anti - CD20 CHO production cell line : Expression of antibodies with altered glyeoforms leads to an increase in ADCC through higher affinity for FC gamma Rill. Biotechnol Bioeng,2001,74 (4) :288.
  • 7Satoh M, Iida S, Shitara K. Non - fueosylated therapeutic antibodies as next - generation therapeutic antibodies. Expert Opin Biol Ther, 2006,6(11) :1161.
  • 8Hodoniczky J, Zheng YZ, James DC. Control of recombinant mono- clonal antibody effector functions by Fc N - glycan remodeling in vitro. Biotechnol Prog ,2005 ,21 (6) :1644.
  • 9Kanda Y, Yamada T. Comparison of biological activity among nonfu- cosylated therapeutic IgG1 antibodies with three different N - linked Fc oligosaccharides : the high - mannose,hybrid, and complex types. Glycobiology, 2007,17 ( 1 ) : 104.
  • 10Gazzano - Santoro H, Ralph P. A non - radioactive complement - de- pendent cytotoxicity assay for anti - CD20 monoclonal antibody. J Immunol Methods, 1997,202 (2) : 163.

共引文献34

同被引文献13

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部